Clinical Trials

Neoplasm Metastasis

NCT03918278 2025-06-25

MK-0482-001

222 enrolled

Neoplasms

NCT02723955 2024-12-27

Dose Escalation and Expansion Study of GSK3359609 in Participants With Selected Advanced Solid Tumors (INDUCE-1)

829 enrolled 100 charts

Neoplasms

NCT01010945 2024-11-21

Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic Cancer

19 enrolled

Adenocarcinoma

NCT03237390 2023-01-05

Ribociclib and Gemcitabine Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors

43 enrolled

Neoplasm Metastasis

NCT02825940 2023-01-04

IMYO29233

120 enrolled

Neoplasms

NCT03669601 2021-06-04

ATRiUM

Phase 1 Unknown

55 enrolled

Neoplasm Metastasis, Neoplasms

NCT02559674 2020-01-27

QUILT-2.001: ALT-803 in Patients With Advanced Pancreatic Cancer in Conjunction With Gemcitabine and Nab-Paclitaxel

8 enrolled

Neoplasm Metastasis, Neoplasms

NCT03307148 2020-01-22

STAR_PAC

29 enrolled

Neoplasm Metastasis

NCT02071537 2019-11-25

Chloroquine in Combination With Carboplatin/Gemcitabine in Advanced Solid Tumors

24 enrolled

Neoplasms

NCT01284335 2019-01-10

A Safety Study in Participants With Advanced Solid Tumors

234 enrolled 23 charts

Neoplasm Metastasis

NCT01764828 2018-11-01

BAY86-9766 Plus Gemcitabine Phase I Study in Asian

23 enrolled

Neoplasms

NCT01358968 2018-10-25

A Drug Interaction Study to Assess the Effect of LY2603618 on the Metabolic Pathway of Desipramine

20 enrolled 14 charts

Neoplasms

NCT02045589 2018-10-01

A Phase I Dose Escalation Study of Intratumoral VCN-01 Injections With Gemcitabine and Abraxane® in Patients With Advanced Pancreatic Cancer

8 enrolled

Neoplasm Metastasis, Neoplasms

NCT02620423 2018-09-13

Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma

11 enrolled

Neoplasms

NCT00678132 2018-07-05

AZD2281 and Cisplatin Plus Gemcitabine to Treat Solid Tumor Cancers

23 enrolled

Neoplasms

NCT01342224 2018-04-12

Immunochemoradiotherapy in Patients With Pancreatic Cancer

11 enrolled

Adenocarcinoma, Neoplasms

NCT01285037 2018-02-20

A Study of LY2801653 in Advanced Cancer

190 enrolled

Neoplasms

NCT01460537 2017-10-04

Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer

50 enrolled

Neoplasms

NCT01165905 2017-06-23

Safety of 24-hour Infusion of ON 01910.Na in Combination With Gemcitabine in Advanced Solid Tumors

10 enrolled

Neoplasms

NCT02723838 2017-03-07

Study of Intratumoral REOLYSIN® in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy in Muscle-invasive Transitional Cell Carcinoma of the Bladder

Phase 1 Withdrawn

Neoplasms

NCT00811993 2016-11-02

A Study of R1507 in Combination With Multiple Standard Chemotherapy Treatments in Patients With Advanced Solid Tumors

104 enrolled

Neoplasms

NCT01447225 2016-09-14

Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors

43 enrolled 21 charts

Neoplasms

NCT02317419 2016-07-26

A Study of RO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid Tumors

15 enrolled

Neoplasms

NCT00422682 2016-06-10

A Study Evaluating BSI-201 in Combination With Chemotherapeutic Regimens in Subjects With Advanced Solid Tumors

136 enrolled

Neoplasms

NCT01057264 2015-11-18

HAI Abraxane With Gemcitabine and Bevacizumab

78 enrolled

Neoplasms

NCT01674556 2015-09-24

Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer

25 enrolled

Adenocarcinoma, Neoplasms

NCT01970553 2015-04-01

Escalating Doses of PM01183 in Combination With Gemcitabine in Patients With Specific Unresectable Solid Tumors

47 enrolled

Neoplasms

NCT01455532 2014-10-22

A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors

59 enrolled

Neoplasms

NCT00398697 2014-02-13

Phase I Perifosine and Gemcitabine Study

19 enrolled

Neoplasms

NCT00660426 2013-04-23

Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors

30 enrolled

Neoplasms

NCT00874042 2012-07-23

Dose Escalation Study of ARQ 197 in Combination With Gemcitabine in Adult Patients With Advanced Solid Tumors

74 enrolled

Neoplasms

NCT01204996 2012-05-30

A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid Tumors

53 enrolled

Neoplasms

NCT00454649 2012-04-04

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

102 enrolled 48 charts

Neoplasms

NCT00437203 2012-04-03

PF-00477736 Is Being Studied In Advanced Solid Tumors In Combination With Chemotherapy With Gemcitabine

43 enrolled 16 charts

Neoplasms

NCT00937664 2011-02-07

Safety and Tolerability Study of AZD7762 in Combination With Gemcitabine

24 enrolled

Neoplasms

NCT00733031 2010-12-10

Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD6918

75 enrolled

Neoplasms

NCT00778128 2010-09-06

A Phase I Clinical Study of Oral CP-4126 in Patients With Advanced Solid Tumour

26 enrolled

Neoplasm Metastasis, Neoplasms

NCT00615446 2010-04-30

A Study To Find The Best Doses Of SU011248 And Gemcitabine When Given Together To Patients With Advanced Solid Tumors

44 enrolled

Neoplasms

NCT00001449 2008-03-04

A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients

60 enrolled